MRKR - Marker Therapeutics Inc
IEX Last Trade
3.6
0.100 2.778%
Share volume: 15,181
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.50
0.10
2.86%
Summary score
19%
Profitability
25%
Dept financing
4%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-115.74%
Return on assets
-48.53%
Return on sales
0%
Return on invested capital
484.08%
Total debt ratio
26.3%
Debt ratio change over timeo
-0.82%
Current Ratio
9.28%
Quick Ratio
0%
Cash Position Ratio
9.9%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-14.43%
Return on assets
-12.79%
Return on sales
0%
Return on invested capital
227.35%
Total debt ratio
12.13%
Debt ratio change over timeo
-0.96%
Current Ratio
14.73%
Quick Ratio
0%
Cash Position Ratio
14.1%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-18.37%
Return on assets
-13.1%
Return on sales
0%
Return on invested capital
-72.23%
Total debt ratio
28.87%
Debt ratio change over time
-0.9%
Current Ratio
6.97%
Quick Ratio
0%
Cash Position Ratio
6.45%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-185.8%
Return on assets
-136.06%
Return on sales
0%
Return on invested capital
272.16%
Total debt ratio
-81.94%
Debt ratio change over time
-0.82%
Current Ratio
3.55%
Quick Ratio
0%
Cash Position Ratio
3.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRKR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -115.74% | -3.05% | 11.55% | 6.27% |
| Return on assets | -48.53% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 484.08% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 36% | 67% | 59% |
| Total debt ratio | 26.3% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.82% | 6.09% | 6.03% | 1.53% |
| Dept financing | 6% | 50% | 43% | 14% |
| Current Ratio | 14.73% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 14.1% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 16% | 36% | 36% |
| Short-term ratios | MRKR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -14.43% | -25.62% | 17.94% | 7.14% |
| Return on assets | -12.79% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 227.35% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 59% |
| Total debt ratio | 12.13% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.96% | -23.44% | 9.66% | 0.6% |
| Dept financing | 3% | 25% | 45% | 8% |
| Current Ratio | 14.73% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 14.1% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 23% | 20% | 34% |